...
首页> 外文期刊>Bioconjugate Chemistry >Folate-Vinca Alkaloid Conjugates for Cancer Therapy: A Structure-Activity Relationship
【24h】

Folate-Vinca Alkaloid Conjugates for Cancer Therapy: A Structure-Activity Relationship

机译:叶酸-长春花生物碱共轭用于癌症治疗:结构-活动关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Vintafolide is a potent Mate-targeted vinca alkaloid small molecule drug conjugate (SMDC) that has shown promising results in multiple clinical oncology studies. Structurally, vintafolide consists of 4 essential modules: (l) folic acid, (2) a hydrophilic peptide spacer, (3) a disulfide-containing, self-immolative linker, and (4) the cytotoxic drug, desacetylvin-blastine hydrazide (DAVLBH). Here, we report a structure-activity study evaluating the biological impact of (i) substituting DAVLBH within the vintafolide molecule with other vinca alkaloid analogues such as vincristine, vindesine, vinflunine, or vinorelbine; (ii) substituting the naturally (S)-configured Asp-Arg-Asp-Asp-Cys peptide with alternative hydrophilic spacers of varied composition; and (iii) varying the composition of the linker module. A series of vinca alkaloid-containing SMDCs were synthesized and purified by HPLC and LCMS. The SMDCs were screened in vitro against folate receptor (FR)-positive cells, and anti-tumor activity was tested against well-established subcutaneous FR-positive tumor xenografts. The cytotoxic and anti-tumor activity was directly compared to that produced by vintafolide. Among all the folate vinca alkaloid SMDCs tested, DAVLBH-containing SMDCs were active, while those constructed with vincristine, vindesine, or vinorelbine analogues failed to produce meaningful biological activity. Within the DAVLBH series, having a bioreleasable, self-immolative linker system was found to be critical for activity since multiple analogues constructed with thioether-based linkers all failed to produce meaningful activity both in vitro and in vivo. Substitutions of some or all of the natural amino acids within vintafolide's hydrophilic spacer module did not significantly change the in vitro or in vivo potency of the SMDCs. Vintafolide remains one of the most potent folate-vinca alkaloid SMDCs produced to date, and continued clinical development is warranted.
机译:Vintafolide是一种有效的靶向Mate的长春花生物碱小分子药物偶联物(SMDC),在多项临床肿瘤学研究中已显示出令人鼓舞的结果。从结构上讲,长春花环素由4个基本模块组成:(l)叶酸,(2)亲水性肽间隔基,(3)含二硫键的自消灭性接头和(4)细胞毒性药物脱乙酰基vin-blastine肼(DAVLBH) )。在此,我们报告了一项结构活性研究,该研究评估了(i)用其他长春花碱生物碱类似物(如长春新碱,长春地辛,长春氟宁或长春瑞滨)取代长春新碱分子中的DAVLBH的生物学影响; (ii)将天然(S)构型的Asp-Arg-Asp-Asp-Cys肽替换为具有不同组成的替代性亲水间隔基; (iii)改变链接器模块的组成。合成了一系列含有长春花生物碱的SMDC,并通过HPLC和LCMS进行了纯化。在体外针对叶酸受体(FR)阳性细胞筛选了SMDC,并针对成熟的皮下FR阳性肿瘤异种移植物测试了抗肿瘤活性。将细胞毒性和抗肿瘤活性直接与长春花环素产生的活性进行了比较。在测试的所有叶酸长春花生物碱SMDC中,含DAVLBH的SMDC均具有活性,而用长春新碱,长春地辛或长春瑞滨类似物构建的那些则不能产生有意义的生物学活性。在DAVLBH系列中,发现具有生物可释放的自消灭性接头系统对于活性至关重要,因为用基于硫醚的接头构建的多个类似物在体外和体内均无法产生有意义的活性。在vintafolide的亲水性间隔物模块内取代部分或全部天然氨基酸不会显着改变SMDC的体外或体内效力。 Vintafolide仍然是迄今为止生产的最有效的叶酸-长春花生物碱SMDC之一,并且有必要继续进行临床开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号